BioCentury
ARTICLE | Clinical News

R-albuterol: Began Phase II trial to compare bronchodilatory effect with racemic albuterol in 20 patients to be enrolled in the placebo-controlled, double-blind

April 10, 1995 7:00 AM UTC

Sepracor Inc. (SEPR), Marlborough, Mass. Product: R-albuterol, the separated isomer of racemic, R,S-albuterol, a currently marketed bronchodilator Indication: Asthma Status: Began Phase II trial to co...